Cytomedix (GTF) Beats Q3 Views by 1c

November 11, 2009 4:24 PM EST

Cytomedix (NYSE: GTF) reports Q3 loss of $0.02, 1 cent better than the analyst estimate of ($0.03). Revenue for the quarter was $538,000, which compares to the estimate of $600,000.


Related Categories

Earnings

Stocks Mentioned

GTF 0.46

+0.00 +0.00%
Volume: 51,245
Track GTF


Add Your Comment